FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to simplify the consumer underwriting journey, and to support consumer health and wellness engagement. It offers FOXO Labs, a epigenetic biomarker technology to assess underwriting factors used in life insurance underwriting from a saliva specimen; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is headquartered in Minneapolis, Minnesota. FOXO Technologies Inc. operates as a subsidiary of FOXO Management LLC.